The latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance (Q33212237)

24 July 2017

1 reference

title

The latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance (English)

1 reference

24 July 2017

Ann Noë

1 reference

24 July 2017

Jean Plum

series ordinal

1 reference

24 July 2017

Chris Verhofstede

series ordinal

1 reference

24 July 2017

language of work or name

English

0 references

publication date

22 February 2005

1 reference

Journal of Antimicrobial Chemotherapy

24 July 2017

published in

1 reference

24 July 2017

1 reference

24 July 2017

1 reference

24 July 2017

page(s)

410-412

1 reference

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

The challenge of viral reservoirs in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

Latency in human immunodeficiency virus type 1 infection: no easy answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

The lymphocyte HIV reservoir in patients on long-term HAART is a memory of virus evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

Drug-resistant variants that evolve during nonsuppressive therapy persist in HIV-1-infected peripheral blood mononuclear cells after long-term highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

Practical applications of viral fitness in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

Immunologic and Virologic Consequences of Temporary Antiretroviral Treatment Interruption in Clinical Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI038

21 January 2018

Identifiers

DOI

10.1093/JAC/DKI038

1 reference

24 July 2017

1 reference